technetium-tc-99m-tetrofosmin and Hypopharyngeal-Neoplasms

technetium-tc-99m-tetrofosmin has been researched along with Hypopharyngeal-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-tetrofosmin and Hypopharyngeal-Neoplasms

ArticleYear
Application of Tc-99m-tetrofosmin as a tumor imaging agent: comparison with Tl-201.
    Annals of nuclear medicine, 1996, Volume: 10, Issue:2

    Tc-99m-tetrofosmin SPECT was performed on 6 occasions in 4 patients with hypopharyngeal carcinoma, lung carcinoma, esophageal carcinoma and maxillary plasmocytoma and compared with Tl-201 SPECT. All lesions accumulated both Tc-99m-tetrofosmin and Tl-201. Early uptake ratios of Tc-99m-tetrofosmin were about 2 but those of Tl-201 were much higher (more than 3). Washout rates of Tc-99m-tetrofosmin were higher than those of Tl-201. There was a good positive correlation between the early uptake ratio of Tc-99m-tetrofosmin and that of Tl-201. The delayed uptake ratio and washout rate showed poor correlation. In conclusion, early uptakes of both the agents were similar but their retention patterns were different. Tc-99m-tetrofosmin may be used for tumor imaging though more studies are required to evaluate diagnostic accuracy and the significance of delayed images.

    Topics: Aged; Esophageal Neoplasms; Female; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maxillary Sinus Neoplasms; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Plasmacytoma; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

1996